annual EBITDA:
$16.40B+$6.84B(+71.60%)Summary
- As of today (April 12, 2025), PFE annual EBITDA is $16.40 billion, with the most recent change of +$6.84 billion (+71.60%) on December 1, 2024.
- During the last 3 years, PFE annual EBITDA has fallen by -$14.39 billion (-46.74%).
- PFE annual EBITDA is now -60.03% below its all-time high of $41.03 billion, reached on December 31, 2022.
Performance
PFE EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$2.09B-$5.17B(-71.21%)Summary
- As of today (April 12, 2025), PFE quarterly EBITDA is $2.09 billion, with the most recent change of -$5.17 billion (-71.21%) on December 1, 2024.
- Over the past year, PFE quarterly EBITDA has stayed the same.
- PFE quarterly EBITDA is now -83.83% below its all-time high of $12.91 billion, reached on June 1, 2022.
Performance
PFE quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$17.69B+$3.86B(+27.89%)Summary
- As of today (April 12, 2025), PFE TTM EBITDA is $17.69 billion, with the most recent change of +$3.86 billion (+27.89%) on December 1, 2024.
- Over the past year, PFE TTM EBITDA has stayed the same.
- PFE TTM EBITDA is now -56.88% below its all-time high of $41.03 billion, reached on December 31, 2022.
Performance
PFE TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
PFE EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +71.6% | 0.0% | 0.0% |
| 3 y3 years | -46.7% | 0.0% | 0.0% |
| 5 y5 years | -12.1% | 0.0% | 0.0% |
PFE EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -60.0% | +71.6% | -83.8% | +217.9% | -56.9% | +222.6% |
| 5 y | 5-year | -60.0% | +71.6% | -83.8% | +217.9% | -56.9% | +269.6% |
| alltime | all time | -60.0% | +1607.8% | -83.8% | +128.0% | -56.9% | +905.6% |
Pfizer EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $16.40B(+71.6%) | $2.09B(-71.2%) | $17.69B(+27.9%) |
| Sep 2024 | - | $7.25B(+201.5%) | $13.84B(+152.2%) |
| Jun 2024 | - | $2.41B(-59.5%) | $5.49B(-26.2%) |
| Mar 2024 | - | $5.95B(-435.8%) | $7.43B(-22.3%) |
| Dec 2023 | $9.56B(-76.7%) | -$1.77B(+61.4%) | $9.56B(-48.0%) |
| Sep 2023 | - | -$1.10B(-125.2%) | $18.39B(-38.7%) |
| Jun 2023 | - | $4.35B(-46.1%) | $29.98B(-22.2%) |
| Mar 2023 | - | $8.07B(+14.3%) | $38.55B(-6.1%) |
| Dec 2022 | $41.03B(+33.2%) | $7.06B(-32.7%) | $41.03B(+4.0%) |
| Sep 2022 | - | $10.49B(-18.7%) | $39.45B(+2.6%) |
| Jun 2022 | - | $12.91B(+22.3%) | $38.46B(+12.7%) |
| Mar 2022 | - | $10.56B(+92.8%) | $34.12B(+10.8%) |
| Dec 2021 | $30.79B(+132.2%) | $5.48B(-42.4%) | $30.80B(+12.1%) |
| Sep 2021 | - | $9.51B(+10.9%) | $27.47B(+36.8%) |
| Jun 2021 | - | $8.57B(+18.5%) | $20.08B(+24.7%) |
| Mar 2021 | - | $7.24B(+236.7%) | $16.10B(+21.4%) |
| Dec 2020 | $13.26B(-28.9%) | $2.15B(+1.2%) | $13.26B(+177.0%) |
| Sep 2020 | - | $2.12B(-53.8%) | $4.79B(-68.8%) |
| Jun 2020 | - | $4.59B(+4.4%) | $15.35B(-8.7%) |
| Mar 2020 | - | $4.40B(-169.5%) | $16.82B(-9.8%) |
| Dec 2019 | $18.65B(+68.6%) | -$6.33B(-149.8%) | $18.65B(+6.5%) |
| Sep 2019 | - | $12.69B(+109.5%) | $17.52B(+60.3%) |
| Jun 2019 | - | $6.06B(-2.7%) | $10.93B(-3.2%) |
| Mar 2019 | - | $6.23B(-183.5%) | $11.29B(+2.0%) |
| Dec 2018 | $11.06B(-44.3%) | -$7.46B(-222.3%) | $11.06B(-48.3%) |
| Sep 2018 | - | $6.10B(-4.9%) | $21.38B(+3.0%) |
| Jun 2018 | - | $6.42B(+6.8%) | $20.75B(+3.6%) |
| Mar 2018 | - | $6.00B(+110.1%) | $20.03B(+1.0%) |
| Dec 2017 | $19.84B(+29.8%) | $2.86B(-47.8%) | $19.84B(+1.2%) |
| Sep 2017 | - | $5.47B(-4.0%) | $19.61B(+12.5%) |
| Jun 2017 | - | $5.70B(-2.0%) | $17.43B(+10.2%) |
| Mar 2017 | - | $5.82B(+121.8%) | $15.82B(+3.4%) |
| Dec 2016 | $15.29B(-0.2%) | $2.62B(-20.3%) | $15.29B(+8.6%) |
| Sep 2016 | - | $3.29B(-19.5%) | $14.08B(-6.4%) |
| Jun 2016 | - | $4.09B(-22.7%) | $15.03B(-5.8%) |
| Mar 2016 | - | $5.29B(+276.7%) | $15.96B(+4.2%) |
| Dec 2015 | $15.32B(-19.9%) | $1.41B(-66.9%) | $15.32B(-12.0%) |
| Sep 2015 | - | $4.25B(-15.4%) | $17.40B(-5.5%) |
| Jun 2015 | - | $5.02B(+7.9%) | $18.41B(-3.9%) |
| Mar 2015 | - | $4.65B(+33.4%) | $19.16B(+0.1%) |
| Dec 2014 | $19.14B(-18.7%) | $3.49B(-33.7%) | $19.14B(-6.9%) |
| Sep 2014 | - | $5.26B(-8.9%) | $20.55B(-0.9%) |
| Jun 2014 | - | $5.77B(+24.8%) | $20.73B(-7.0%) |
| Mar 2014 | - | $4.62B(-5.6%) | $22.29B(-5.3%) |
| Dec 2013 | $23.54B(+15.3%) | $4.90B(-9.9%) | $23.54B(+1.5%) |
| Sep 2013 | - | $5.43B(-26.0%) | $23.20B(+2.6%) |
| Jun 2013 | - | $7.34B(+25.0%) | $22.61B(+5.2%) |
| Mar 2013 | - | $5.87B(+28.8%) | $21.50B(+4.0%) |
| Dec 2012 | $20.42B(-8.0%) | $4.56B(-5.9%) | $20.68B(+1.8%) |
| Sep 2012 | - | $4.84B(-22.3%) | $20.30B(-6.2%) |
| Jun 2012 | - | $6.23B(+23.4%) | $21.64B(+0.4%) |
| Mar 2012 | - | $5.05B(+20.5%) | $21.55B(-2.9%) |
| Dec 2011 | $22.19B(+12.8%) | $4.19B(-32.3%) | $22.18B(+3.9%) |
| Sep 2011 | - | $6.18B(+0.7%) | $21.34B(+11.0%) |
| Jun 2011 | - | $6.13B(+8.0%) | $19.23B(-2.0%) |
| Mar 2011 | - | $5.68B(+69.7%) | $19.63B(-0.2%) |
| Dec 2010 | $19.67B(+16.9%) | $3.35B(-17.8%) | $19.67B(+6.0%) |
| Sep 2010 | - | $4.07B(-37.7%) | $18.56B(-6.3%) |
| Jun 2010 | - | $6.53B(+14.1%) | $19.80B(+10.9%) |
| Mar 2010 | - | $5.72B(+155.2%) | $17.86B(+2.0%) |
| Dec 2009 | $16.82B(+9.9%) | $2.24B(-57.8%) | $17.50B(+11.6%) |
| Sep 2009 | - | $5.31B(+15.8%) | $15.68B(+1.9%) |
| Jun 2009 | - | $4.59B(-14.5%) | $15.39B(+1.1%) |
| Mar 2009 | - | $5.37B(+1183.5%) | $15.22B(+0.5%) |
| Dec 2008 | $15.30B(-1.5%) | $418.00M(-91.7%) | $15.14B(-17.8%) |
| Sep 2008 | - | $5.02B(+13.5%) | $18.42B(+18.0%) |
| Jun 2008 | - | $4.42B(-16.4%) | $15.60B(+5.4%) |
| Mar 2008 | - | $5.29B(+43.2%) | $14.81B(-4.7%) |
| Dec 2007 | $15.54B(-20.6%) | $3.69B(+67.6%) | $15.54B(-1.1%) |
| Sep 2007 | - | $2.20B(-39.2%) | $15.71B(-16.0%) |
| Jun 2007 | - | $3.62B(-39.8%) | $18.70B(-6.1%) |
| Mar 2007 | - | $6.02B(+55.7%) | $19.93B(+1.8%) |
| Dec 2006 | $19.57B(-1.0%) | $3.86B(-25.7%) | $19.57B(-4.8%) |
| Sep 2006 | - | $5.20B(+7.2%) | $20.55B(+1.4%) |
| Jun 2006 | - | $4.85B(-14.4%) | $20.28B(+1.0%) |
| Mar 2006 | - | $5.66B(+16.9%) | $20.08B(+0.6%) |
| Dec 2005 | $19.78B(-8.1%) | $4.84B(-1.6%) | $19.95B(-2.8%) |
| Sep 2005 | - | $4.92B(+5.9%) | $20.51B(-3.6%) |
| Jun 2005 | - | $4.65B(-16.0%) | $21.28B(-1.0%) |
| Mar 2005 | - | $5.54B(+2.3%) | $21.50B(-0.1%) |
| Dec 2004 | $21.52B | $5.41B(-4.9%) | $21.52B(+4.9%) |
| Sep 2004 | - | $5.69B(+16.8%) | $20.51B(+10.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2004 | - | $4.87B(-12.2%) | $18.51B(+12.6%) |
| Mar 2004 | - | $5.55B(+26.0%) | $16.44B(+12.2%) |
| Dec 2003 | $14.39B(+8.5%) | $4.40B(+19.5%) | $14.65B(+3.5%) |
| Sep 2003 | - | $3.69B(+31.5%) | $14.15B(+2.7%) |
| Jun 2003 | - | $2.80B(-25.5%) | $13.78B(+0.6%) |
| Mar 2003 | - | $3.76B(-3.6%) | $13.70B(+3.3%) |
| Dec 2002 | $13.26B(+14.4%) | $3.90B(+17.7%) | $13.26B(+10.7%) |
| Sep 2002 | - | $3.31B(+22.1%) | $11.97B(+1.9%) |
| Jun 2002 | - | $2.72B(-18.3%) | $11.75B(-1.2%) |
| Mar 2002 | - | $3.32B(+26.9%) | $11.88B(+2.4%) |
| Dec 2001 | $11.59B(+21.5%) | $2.62B(-15.2%) | $11.60B(+0.1%) |
| Sep 2001 | - | $3.09B(+8.2%) | $11.60B(+5.6%) |
| Jun 2001 | - | $2.85B(-6.2%) | $10.98B(+7.3%) |
| Mar 2001 | - | $3.04B(+16.4%) | $10.23B(+7.0%) |
| Dec 2000 | $9.54B(+21.2%) | $2.61B(+5.7%) | $9.56B(+4.7%) |
| Sep 2000 | - | $2.47B(+17.5%) | $9.13B(+8.0%) |
| Jun 2000 | - | $2.10B(-11.5%) | $8.46B(+1.1%) |
| Mar 2000 | - | $2.38B(+8.9%) | $8.37B(+15.0%) |
| Dec 1999 | $7.87B(+28.0%) | $2.18B(+21.2%) | $7.28B(-9.0%) |
| Sep 1999 | - | $1.80B(-10.7%) | $7.99B(+8.2%) |
| Jun 1999 | - | $2.01B(+56.8%) | $7.39B(+15.1%) |
| Mar 1999 | - | $1.28B(-55.7%) | $6.42B(+4.1%) |
| Dec 1998 | $6.15B(+75.6%) | $2.90B(+143.0%) | $6.17B(+49.8%) |
| Sep 1998 | - | $1.19B(+14.1%) | $4.12B(+6.1%) |
| Jun 1998 | - | $1.04B(+1.4%) | $3.88B(+6.0%) |
| Mar 1998 | - | $1.03B(+21.7%) | $3.66B(-0.4%) |
| Dec 1997 | $3.50B(+12.9%) | $847.00M(-11.2%) | $3.67B(+10.0%) |
| Sep 1997 | - | $954.00M(+15.4%) | $3.34B(+0.5%) |
| Jun 1997 | - | $827.00M(-20.8%) | $3.32B(+4.6%) |
| Mar 1997 | - | $1.04B(+103.1%) | $3.17B(+4.4%) |
| Dec 1996 | $3.10B(+5.7%) | $514.00M(-45.1%) | $3.04B(-8.1%) |
| Sep 1996 | - | $937.00M(+37.8%) | $3.31B(+5.1%) |
| Jun 1996 | - | $680.00M(-25.3%) | $3.15B(+1.7%) |
| Mar 1996 | - | $910.00M(+16.4%) | $3.10B(+5.6%) |
| Dec 1995 | $2.93B(+29.6%) | $781.60M(+0.6%) | $2.93B(+7.3%) |
| Sep 1995 | - | $776.70M(+23.9%) | $2.73B(+7.7%) |
| Jun 1995 | - | $626.90M(-16.0%) | $2.54B(+6.7%) |
| Mar 1995 | - | $746.50M(+28.4%) | $2.38B(+4.9%) |
| Dec 1994 | $2.26B(+93.3%) | $581.30M(+0.1%) | $2.27B(+61.2%) |
| Sep 1994 | - | $581.00M(+24.4%) | $1.41B(+5.0%) |
| Jun 1994 | - | $466.90M(-26.7%) | $1.34B(-10.1%) |
| Mar 1994 | - | $636.60M(-328.5%) | $1.49B(+6.2%) |
| Dec 1993 | $1.17B(-31.4%) | -$278.60M(-154.2%) | $1.40B(-33.3%) |
| Sep 1993 | - | $514.20M(-16.6%) | $2.10B(+2.1%) |
| Jun 1993 | - | $616.80M(+12.2%) | $2.06B(+15.6%) |
| Mar 1993 | - | $549.90M(+30.3%) | $1.78B(+4.4%) |
| Dec 1992 | $1.71B(+14.0%) | $422.00M(-10.6%) | $1.71B(+6.3%) |
| Sep 1992 | - | $471.90M(+39.2%) | $1.61B(+2.4%) |
| Jun 1992 | - | $338.90M(-28.6%) | $1.57B(+2.0%) |
| Mar 1992 | - | $474.50M(+48.0%) | $1.54B(+2.7%) |
| Dec 1991 | $1.50B(+17.1%) | $320.50M(-26.3%) | $1.50B(+3.7%) |
| Sep 1991 | - | $434.80M(+40.8%) | $1.44B(+3.6%) |
| Jun 1991 | - | $308.70M(-28.9%) | $1.39B(+3.2%) |
| Mar 1991 | - | $434.00M(+62.6%) | $1.35B(+5.6%) |
| Dec 1990 | $1.28B(+8.8%) | $266.90M(-30.7%) | $1.28B(-158.3%) |
| Sep 1990 | - | $385.20M(+45.2%) | -$2.20B(+92.1%) |
| Jun 1990 | - | $265.20M(-26.8%) | -$1.14B(+982.5%) |
| Mar 1990 | - | $362.50M(-111.3%) | -$105.60M(-110.9%) |
| Dec 1989 | $1.18B(-2.6%) | -$3.21B(-323.1%) | $968.20M(-17.4%) |
| Sep 1989 | - | $1.44B(+10.4%) | $1.17B(+5.0%) |
| Jun 1989 | - | $1.30B(-9.3%) | $1.12B(-2.9%) |
| Mar 1989 | - | $1.44B(-147.8%) | $1.15B(+13.7%) |
| Dec 1988 | $1.21B(+9.4%) | -$3.01B(-317.3%) | $1.01B(-23.0%) |
| Sep 1988 | - | $1.38B(+3.5%) | $1.31B(+6.9%) |
| Jun 1988 | - | $1.34B(+3.0%) | $1.23B(+9.8%) |
| Mar 1988 | - | $1.30B(-148.0%) | $1.12B(+19.0%) |
| Dec 1987 | $1.10B(-0.4%) | -$2.70B(-308.3%) | $940.80M(-27.1%) |
| Sep 1987 | - | $1.30B(+5.8%) | $1.29B(+11.7%) |
| Jun 1987 | - | $1.23B(+9.6%) | $1.16B(+10.4%) |
| Mar 1987 | - | $1.12B(-147.6%) | $1.05B(+9.1%) |
| Dec 1986 | $1.11B(+9.6%) | -$2.35B(-302.3%) | $959.70M(-21.8%) |
| Sep 1986 | - | $1.16B(+4.0%) | $1.23B(+14.0%) |
| Jun 1986 | - | $1.12B(+8.3%) | $1.08B(+12.1%) |
| Mar 1986 | - | $1.03B(-149.5%) | $960.20M(+9.9%) |
| Dec 1985 | $1.01B(+5.1%) | -$2.09B(-306.0%) | $873.80M(-3.5%) |
| Sep 1985 | - | $1.01B(+1.1%) | $905.70M(+3.4%) |
| Jun 1985 | - | $1.00B(+5.9%) | $875.60M(+1.9%) |
| Mar 1985 | - | $945.70M(-146.0%) | $859.40M(+3.1%) |
| Dec 1984 | $960.30M | -$2.05B(-309.1%) | $833.50M(-71.1%) |
| Sep 1984 | - | $982.70M(-0.3%) | $2.89B(+51.6%) |
| Jun 1984 | - | $985.70M(+7.2%) | $1.91B(+107.2%) |
| Mar 1984 | - | $919.80M | $919.80M |
FAQ
- What is Pfizer annual EBITDA?
- What is the all time high annual EBITDA for Pfizer?
- What is Pfizer annual EBITDA year-on-year change?
- What is Pfizer quarterly EBITDA?
- What is the all time high quarterly EBITDA for Pfizer?
- What is Pfizer quarterly EBITDA year-on-year change?
- What is Pfizer TTM EBITDA?
- What is the all time high TTM EBITDA for Pfizer?
- What is Pfizer TTM EBITDA year-on-year change?
What is Pfizer annual EBITDA?
The current annual EBITDA of PFE is $16.40B
What is the all time high annual EBITDA for Pfizer?
Pfizer all-time high annual EBITDA is $41.03B
What is Pfizer annual EBITDA year-on-year change?
Over the past year, PFE annual EBITDA has changed by +$6.84B (+71.60%)
What is Pfizer quarterly EBITDA?
The current quarterly EBITDA of PFE is $2.09B
What is the all time high quarterly EBITDA for Pfizer?
Pfizer all-time high quarterly EBITDA is $12.91B
What is Pfizer quarterly EBITDA year-on-year change?
Over the past year, PFE quarterly EBITDA has changed by $0.00 (0.00%)
What is Pfizer TTM EBITDA?
The current TTM EBITDA of PFE is $17.69B
What is the all time high TTM EBITDA for Pfizer?
Pfizer all-time high TTM EBITDA is $41.03B
What is Pfizer TTM EBITDA year-on-year change?
Over the past year, PFE TTM EBITDA has changed by $0.00 (0.00%)